Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Citi Pharma's dividends per share for the
six
months ended in . 20 was ₨0.00. Its dividends per share for the trailing twelve months (TTM) ended in . 20 was ₨0.00. Its Dividend Payout Ratio for the
six
months ended in . 20 was 0.00. As of today, Citi Pharma's Dividend Yield % is 4.76%.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Citi Pharma Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
PKR 3.500000
2025-10-17
2025-10-20
2025-11-05
Cash Dividend
annually
PKR:PKR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Citi Pharma's Dividend Yield (%) for Today is calculated as
Current Share Price is ₨73.53.
Citi Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₨3.5.
During the past 0 years, the highest Dividend Yield of Citi Pharma was 4.99%. The lowest was 0.00%. And the median was 0.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Citi Pharma Dividends per Share Related Terms
Citi Pharma Dividends per Share Historical Data
* Premium members only.
The historical data trend for Citi Pharma's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Citi Pharma Dividends per Share Chart
Citi Pharma Annual Data
Trend
Dividends per Share
Citi Pharma Semi-Annual Data
Dividends per Share
KAR:CPHL vs ZTS, UTHR, VTRS: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Citi Pharma Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Citi Pharma's Dividend Yield % falls into.
Citi Pharma (KAR:CPHL) has a Dividends per Share of ₨0.00 as of . 20. Dividends per share represents the per-share amount paid as dividends. View historical data on Citi Pharma and its competitors.
Is Citi Pharma's Dividends per Share too high?
Citi Pharma's current Dividends per Share is ₨0.00. Overall, Citi Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Citi Pharma's Dividends per Share compare to ZTS and UTHR?
Citi Pharma's Dividends per Share of ₨0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Citi Pharma and its competitors. Citi Pharma's current Dividends per Share is ₨0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citi Pharma stock overvalued right now?
Citi Pharma (KAR:CPHL) has a current Dividends per Share of ₨0.00. The current Dividends per Share is ₨0.00. Citi Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Citi Pharma (KAR:CPHL), the current Dividends per Share is ₨0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its product portfolio includes API segment, Formulation segment, Cephalosporin formulation, and Nutraceuticals. The API segment includes Paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, and Ibuprofen.
15GF Score
Get the complete analysis for KAR:CPHL
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:CPHL has been successfully added to your 
